Holen Sie sich die Stockscreener-App
10.43
0.29%
-0.03
Handel nachbörslich:
10.56
0.13
+1.25%
Schlusskurs vom Vortag:
$10.46
Offen:
$10.44
24-Stunden-Volumen:
854.73K
Relative Volume:
0.70
Marktkapitalisierung:
$880.06M
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-13.55
EPS:
-0.77
Netto-Cashflow:
$-52.85M
1W Leistung:
-5.53%
1M Leistung:
+3.99%
6M Leistung:
-18.45%
1J Leistung:
+56.84%
1-Tages-Spanne:
$10.17
$10.55
1-Wochen-Bereich:
$10.17
$11.08
52-Wochen-Spanne:
$6.06
$16.99
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Liquidia (LQDA) to Release Quarterly Earnings on Monday - MarketBeat
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024 - Yahoo Finance
Liquidia Corp's chief business officer sells shares worth $5,190 - Investing.com India
Liquidia Corp's chief business officer sells shares worth $5,190 By Investing.com - Investing.com Canada
Liquidia Technologies, Inc. (LQDA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Analysts Set Liquidia Co. (NASDAQ:LQDA) PT at $24.67 - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - PR Newswire
Liquidia CEO Roger Jeffs sells $89,450 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells $16,961 in stock By Investing.com - Investing.com South Africa
Liquidia's chief business officer sells $12,729 in stock - Investing.com India
Liquidia's chief commercial officer sells $16,961 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock - Investing.com India
Liquidia corp CFO Michael Kaseta sells $43,231 in stock By Investing.com - Investing.com Australia
Liquidia Corp (LQDA) rating upgrades by Raymond James - Knox Daily
Liquidia's general counsel Russell Schundler sells shares worth $28,613 By Investing.com - Investing.com Australia
Liquidia's chief medical officer sells $25,103 in stock By Investing.com - Investing.com Canada
Liquidia's general counsel Russell Schundler sells shares worth $28,613 - Investing.com India
Liquidia's chief medical officer sells $25,103 in stock - Investing.com India
Russell Schundler Sells 2,576 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia CEO Roger Jeffs sells $89,450 in stock - Investing.com
Daily Market Movement: Liquidia Corp (LQDA) Sees a 0.45 Increase, Closing at 11.14 - The Dwinnex
A year in review: Liquidia Corp (LQDA)’s performance in the last year - US Post News
Check out these key findings about Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Shares Fall -0.54 % on Thursday - Knox Daily
Financial Metrics Check: Liquidia Corp (LQDA)’s Ratios for Trailing Twelve Months - The Dwinnex
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigating Challenges and Opportunities ... - Yahoo Finance
Liquidia Corp (LQDA) Q2 2024 Earnings Call Highlights: Navigatin - GuruFocus.com
Liquidia Corp (LQDA) shows promising results - US Post News
Liquidia shares keep strong buy rating as Supreme Court denies UTHR patent appeal - Investing.com
LQDA (Liquidia Corp) may reap gains as insiders became active recently - Knox Daily
Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains? - Yahoo Finance
Liquidia shares jump 11% on court ruling - The Pharma Letter
Liquidia Corp (LQDA) Performance and Fundamentals Dashboard tells a completely different story - SETE News
BTIG maintains Buy rating on Liquidia with $25 target - Investing.com
Liquidia Corp (LQDA) Stock: A Year of Market Fluctuations - The InvestChronicle
Liquidia (NASDAQ:LQDA) Sees Strong Trading VolumeWhat's Next? - MarketBeat
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent - GlobeNewswire Inc.
Lifesci Capital Weighs in on Liquidia Co.'s Q3 2024 Earnings (NASDAQ:LQDA) - MarketBeat
Liquidia Corporation - The Pharma Letter
Liquidia Corp [NASDAQ: LQDA] Sees Increase in Stock Value - Knox Daily
Liquidia (NASDAQ:LQDA) Upgraded at Lifesci Capital - MarketBeat
Liquidia Technologies shares maintain Outperform rating from LifeSci Capital - Investing.com
Evaluating Liquidia: Insights From 14 Financial Analysts - Benzinga
Liquidia (NASDAQ:LQDA) Now Covered by Analysts at Lifesci Capital - MarketBeat
Liquidia Technologies shares maintain Outperform rating from LifeSci Capital By Investing.com - Investing.com UK
Results from Liquidia Corp (LQDA) show risk - US Post News
Liquidia and Pharmosa announce biobucks partnership to develop L606 - The Pharma Letter
Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Liquidia Co. (NASDAQ:LQDA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606) - Yahoo Finance
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schundler Russell | General Counsel |
Oct 14 '24 |
Sale |
11.11 |
2,576 |
28,613 |
486,048 |
| Saggar Rajeev | Chief Medical Officer |
Oct 14 '24 |
Sale |
11.11 |
2,260 |
25,103 |
207,383 |
| Moomaw Scott | Chief Commercial Officer |
Oct 14 '24 |
Sale |
11.11 |
1,527 |
16,961 |
152,798 |
| Kaseta Michael | CFO and COO |
Oct 14 '24 |
Sale |
11.11 |
3,892 |
43,231 |
311,076 |
| JEFFS ROGER | Chief Executive Officer |
Oct 14 '24 |
Sale |
11.11 |
8,053 |
89,450 |
812,193 |
| Adair Jason | Chief Business Officer |
Oct 14 '24 |
Sale |
11.11 |
1,146 |
12,729 |
118,574 |
| Manning Paul B | Director |
Sep 12 '24 |
Buy |
8.90 |
337,078 |
2,999,994 |
816,311 |
| Caligan Partners LP | Director |
Aug 30 '24 |
Buy |
9.51 |
150,000 |
1,426,500 |
6,994,997 |
| Caligan Partners LP | Director |
Aug 30 '24 |
Sale |
9.51 |
150,000 |
1,426,500 |
6,844,997 |
| Adair Jason | Chief Business Officer |
Sep 03 '24 |
Sale |
9.50 |
455 |
4,322 |
115,814 |
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):